Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Grant/Award of 17,000 PLX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 17,000 | n/a |
| Sep 4, 2025 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 7,500 | n/a |
| Aug 12, 2025 | Protalix BioTherapeutics, Inc. (PLX) | Purchase | 129,000 | $205.9K |
| Oct 3, 2023 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 61,676 | n/a |
| Jan 5, 2023 | Protalix BioTherapeutics, Inc. (PLX) | Purchase | 110,000 | $155.8K |
| Sep 9, 2022 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 50,000 | n/a |
| Apr 13, 2020 | Protalix BioTherapeutics, Inc. (PLX) | Purchase | 64,000 | $155.3K |
| Jan 22, 2020 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 40,000 | n/a |